ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 83 filers reported holding ORIC PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,643,746 | -22.0% | 602,272 | 0.0% | 14.84% | +0.6% |
| Q2 2023 | $4,673,631 | +36.1% | 602,272 | 0.0% | 14.75% | +40.1% |
| Q1 2023 | $3,432,950 | -3.2% | 602,272 | 0.0% | 10.53% | -10.0% |
| Q4 2022 | $3,547,382 | +84.1% | 602,272 | 0.0% | 11.70% | +78.7% |
| Q3 2022 | $1,927,000 | -28.6% | 602,272 | 0.0% | 6.55% | -26.5% |
| Q2 2022 | $2,698,000 | -16.1% | 602,272 | 0.0% | 8.92% | +139.4% |
| Q1 2022 | $3,216,000 | -63.7% | 602,272 | 0.0% | 3.72% | -33.1% |
| Q4 2021 | $8,853,000 | -29.7% | 602,272 | 0.0% | 5.56% | -29.1% |
| Q3 2021 | $12,594,000 | +18.2% | 602,272 | 0.0% | 7.85% | +12.7% |
| Q2 2021 | $10,654,000 | -27.8% | 602,272 | 0.0% | 6.96% | -23.4% |
| Q1 2021 | $14,756,000 | -27.6% | 602,272 | 0.0% | 9.10% | +5.4% |
| Q4 2020 | $20,387,000 | – | 602,272 | – | 8.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $99,703,000 | 11.34% |
| Euclidean Capital LLC | 777,193 | $16,251,000 | 7.90% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $12,594,000 | 7.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $21,068,000 | 5.64% |
| EcoR1 Capital, LLC | 3,468,944 | $72,536,000 | 2.52% |
| EMERALD ADVISERS, LLC | 726,236 | $15,186,000 | 0.55% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 742,666 | $15,529,000 | 0.54% |
| Orbimed Advisors | 2,337,574 | $48,879,000 | 0.54% |
| Casdin Capital, LLC | 601,515 | $12,578,000 | 0.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 53,000 | $1,104,000 | 0.27% |